Sidley Austin represented Roche in the transaction, and Cooley represented Poseida Therapeutics. Roche, one of the world’s largest biotechnology companies and the global leader in in-vitro...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Poseida Therapeutics on the deal. Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) and Poseida Therapeutics, Inc. (NASDAQ: PSTX, CEO:...
You must be a Standard 1 Year member to access this content.
Cooley advised Poseida Therapeutics on the deal. Poseida Therapeutics, a clinical-stage biopharmaceutical company, announced its strategic collaboration and license agreement with Roche. The agreement will leverage Poseida’s...
You must be a Standard 1 Year member to access this content.
